Aquis Stock Exchange: Apex constituent review

Summary by AI BETAClose X

Aquis Stock Exchange has announced changes to its Apex segment effective July 20, 2026, following a bi-annual constituent review. Capital for Colleagues Plc will be transferred from the Apex segment to the Access segment because the average market value of its securities for the six months prior to the first Friday of June 2026 was less than £10 million.

Disclaimer*

Aquis Stock Exchange
Aquis Stock Exchange: Apex constituent review

20-Jul-2026 / 07:00 GMT/BST
The issuer is solely responsible for the content of this announcement.


NOTIFICATION OF APEX CONSTITUENT REVIEW

Aquis Stock Exchange announces the following changes to the Apex segment of the Aquis Growth Market following the bi-annual constituent review pursuant to Chapter 6 of the Aquis Growth Market Apex Rulebook. The changes are with effect from Monday, 20 July 2026:

Market value of securities

The following issuer is to be transferred from the Apex segment to the Access segment, as the average market value of the issuer’s securities for the six months prior to the first Friday of June 2026 was less than £10 million:

Capital for Colleagues Plc
Ordinary Shares
Symbol: CFCP
ISIN: GB00BGCZ2V99

The Regulation Department
Aquis Stock Exchange
Level 2, 63 Queen Victoria Street London EC4N 4UA
Tel: 0203 597 6361 Email: aqseregulation@aquis.eu Website: www.aquis.eu


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

View original content: EQS News


End of Announcement - EQS News Service

2367796  20-Jul-2026 

UK 100

Latest directors dealings